Collectively, these findings underscore the impact of the epistatic effects of Siglecg with DNase1 and Dnase1l3 on disease manifestation and highlight the potential combinatory effects of other gene mutations in SLE. The gene discussed is DNASE1L3; the disease is systemic lupus erythematosus.